Parapro LLC
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2002-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.parapro.com
Clinical Trials
11
Trial Phases
4 Phases
Drug Approvals
2
Clinical Trials
Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2021-05-21
- Lead Sponsor
- ParaPRO LLC
- Target Recruit Count
- 280
- Registration Number
- NCT02485704
- Locations
- 🇺🇸
Saint Joseph's Clinical Research, Anaheim, California, United States
🇺🇸Long Beach Clinical Trial Services, Long Beach, California, United States
🇺🇸The Chappel Group Research, Kissimmee, Florida, United States
Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies
- First Posted Date
- 2015-06-30
- Last Posted Date
- 2021-05-19
- Lead Sponsor
- ParaPRO LLC
- Target Recruit Count
- 291
- Registration Number
- NCT02485717
- Locations
- 🇺🇸
Elk Grove Clinical Research, Elk Grove, California, United States
🇺🇸The Chappel Group Research, Kissimmee, Florida, United States
🇺🇸San Marcus Research, Miami, Florida, United States
Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation
- First Posted Date
- 2012-08-08
- Last Posted Date
- 2012-11-22
- Lead Sponsor
- ParaPRO LLC
- Target Recruit Count
- 26
- Registration Number
- NCT01660321
- Locations
- 🇺🇸
Burke Pharmaceutical Research, Hot Springs, Arkansas, United States
🇺🇸Lice Solutions Resource Network, Inc., West Palm Beach, Florida, United States
A Safety and Efficacy Pilot Study Comparing NatrOVA Creme Rinse 1% and NIX Creme Rinse
- Conditions
- Pediculosis CapitisHead Lice
- Interventions
- Drug: NatrOVA Creme Rinse - 1%
- First Posted Date
- 2009-03-09
- Last Posted Date
- 2009-03-09
- Lead Sponsor
- ParaPRO LLC
- Target Recruit Count
- 24
- Registration Number
- NCT00857935
- Locations
- 🇺🇸
Concentrics Research, Indianapolis, Indiana, United States
A Pilot Dose Ranging Study of Spinosad Creme Rinse
- Conditions
- Pediculosis CapitisHead Lice
- Interventions
- First Posted Date
- 2009-03-09
- Last Posted Date
- 2015-10-20
- Lead Sponsor
- ParaPRO LLC
- Target Recruit Count
- 36
- Registration Number
- NCT00858481
- Locations
- 🇺🇸
Hill Top Research, West Palm Beach, Florida, United States
- Prev
- 1
- 2
- 3
- Next
News
Moberg Pharma's MOB-015 Phase 3 Trial Shows Lower Than Expected Clinical Cure Rate
Moberg Pharma reports that a subset of patients in their North American Phase 3 study of MOB-015 achieved clinical cure for nail fungus at a rate lower than anticipated.